Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Find out how to turn your hobbies into a source of extra income. Explore creative ways to monetize what you love doing.
19,037 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Imagine a SpaceX-scale IPO changing how investors price AI startups. This article breaks down what spacex just bigges...
As markets navigated a cautious session, Sunrun’s new framework with Tesla and Renew Home pushed renewable energy equ...
Medicare Advantage mid-year network shifts can leave patients with fewer doctor options until January. Here's what af...
PTIR's double-leveraged bet on Palantir underperformed the stock by nearly half over the past year, underscoring the ...
Berkshire Hathaway under Greg Abel signals a sharper eye for AI champions. Could Alphabet be the catalyst, with Nvidi...
A high-level insider move follows a strong stock run. This article breaks down what the CFO’s sale signals, how to re...
Microsoft’s Satya Nadella signals a data-centric AI strategy, arguing buyers must reveal proprietary know-how to unlo...
Chevron’s move to explore pipeline routes that bypass the Strait of Hormuz could change oil flows and stock risk prof...
A simple, time-tested approach often beats chasing hot sectors. Learn why a broad-market ETF could be your winning mo...
In a hypothetical timeline for risk analysis, the death of the iranian supreme leader in a major attack sparks immedi...
Okta stock popped today after the company highlighted an AI-focused growth path in identity security. This article br...